Eli Lilly and Company insider trading

Bought

—

Sold

$34.6M

4 of 6 on a 10b5-1 plan

Net

−$34.6M

Insiders

5

• Jonsson Patrik10b5-1

  EVP & President, LLY Int'l

  −$7.6M

  Aug 17, 2026

  6,500 sh · $1,175.10

• Zakrowski Donald A10b5-1

  SVP, Finance, & CAO

  −$2.4M

  Aug 10, 2026

  2,000 sh · $1,185.01

• Hakim Anat10b5-1

  EVP, GC & Secretary

  −$6M

  Aug 07, 2026

  5,000 sh · $1,190.00

• Yuffa Ilya10b5-1

  EVP&Pres, LLY USA&Global Capab

  −$2.9M

  Jun 10, 2026

  2,500 sh · $1,150.77

• Lilly Endowment Inc

  Former 10% Shareholder

  −$13.6M

  May 06, 2026

  13,620 sh · $995.23

• Lilly Endowment Inc

  Former 10% Shareholder

  −$2.2M

  May 06, 2026

  2,208 sh · $996.18

Largest purchase

+$1.1M of LLY by Ricks David A (President, Chair, and CEO · Director) on Aug 12, 2025.

Largest sale

−$170.6M of LLY by Lilly Endowment Inc (10% Owner) on Oct 31, 2025.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

Indianapolis, IN

Incorporated in

IN

Listed on

NYSE

SEC Central Index Key

0000059478

Previously filed as

LILLY ELI & CO

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are LLY insiders buying or selling?

Between May 06, 2026 and Aug 17, 2026, 5 Eli Lilly and Company insiders made no open-market purchases and 6 sales worth $34.6M, a net sale of $34.6M. 4 of the sales were pre-scheduled under a Rule 10b5-1 plan.

How much LLY stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 11 Eli Lilly and Company insiders made 9 open-market purchases worth $4.5M and 521 sales worth $5B. 9 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 9 purchases ($4.5M) and 378 sales ($3.8B). The largest purchase was Ricks David A buying $1.1M on Aug 12, 2025. The largest sale was Lilly Endowment Inc selling $170.6M on Oct 31, 2025.

What was the largest recent LLY insider trade?

Lilly Endowment Inc (Former 10% Shareholder) sold $13.6M of LLY stock on May 06, 2026 at about $995.23 a share.

When did an insider last buy LLY shares?

No open-market purchase by a Eli Lilly and Company insider appears in the filings from May 06, 2026 to Aug 17, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Montarce Lucas buying $494.6K on Aug 15, 2025.

Where does LLY insider trading data come from?

From the Form 4 filings Eli Lilly and Company's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.